ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver"

  • 2017 American Transplant Congress

    Electronic Patient Portal Functionality Among Kidney and Liver Transplant Recipients.

    A. Ruiz, K. Smith, J. Wedd, K. Little, S. Pastan, R. Patzer.

    Surgery, Emory University, Atlanta, GA

    IntroductionIn January 2014, all public and private healthcare providers were required to adopt electronic medical records (EMR) into their standard of care. However, little is…
  • 2017 American Transplant Congress

    Preliminary Results of Clinical Normothermic Ex Vivo Liver Perfusion in a North American Setting.

    M. Bral,1 B. Gala-Lopez,1 D. Bigam,1 N. Kneteman,1 A. Malcolm,1 S. Livingstone,1 A. Andres,1 J. Emamaullee,1 L. West,1 P. Friend,2 A. Shapiro.1

    1Department of Surgery, University of Alberta, Edmonton, AB, Canada; 2Department of Surgery, Nuffield Department of Surgical Sciences, Oxford, United Kingdom; 3Oxford Institute of Biomedical Engineering, Oxford, United Kingdom; 4OrganOx, Oxford, United Kingdom

    Outcomes of a first clinical normothermic machine perfusion (NMP) UK liver trial demonstrated feasibility and clear safety, with improved liver function when compared to standard…
  • 2017 American Transplant Congress

    Donor Lymphoid Chimerism in Early Recognition and Prediction of Clinical Outcome Caused by Acute Graft versus Host Disease After Solid Organ Transplant.

    A. Zhang,1 Y. Sun,2 K. Hashimoto,4 M. Fujiki,4 M. Askar,3 J. Fung,5 C. Miller,4 K. Abu-Elmagd,4 B. Eghtesad.4

    1Cleveland Clinic, Allogen Laboratories, Cleveland, OH; 2Avalon University School of Medicine, Willemstad, Netherlands Antilles; 3Baylor University Medical Center, Dallas, TX; 4Transplantation Center, Cleveland Clinic, Cleveland, OH; 5Transplantation Center, University of Chicago, Chicago, IL

    Introduction: Acute graft versus host disease (aGvHD) after solid organ transplant (SOT) is rare but related with high mortality. Early accurate diagnosis is critical for…
  • 2017 American Transplant Congress

    Living Donor Liver Transplantation for Alcoholic Liver Disease.

    H. Braun, J. Dodge, J. Roberts, N. Ascher.

    University of California, San Francisco, San Francisco, CA

    The literature on living donor liver transplantation (LDLT) for alcoholic liver disease (ALD) is sparse. We report our experience w/LDLT for ALD at a single,…
  • 2017 American Transplant Congress

    Pilot Study on Acupuncture in Living Liver and Kidney Donors.

    M. Jesse, M. Kulas, J. Unitis, N. Beltran, M. Abouljoud.

    Transplant Institute, Henry Ford Health System, Detroit

    Pain is an important concern in living donation. The purpose of this study was to test feasibility of integrating an acupuncture intervention pre/post-living donation and…
  • 2017 American Transplant Congress

    MELD-Based Allocation Leads to Inferior Survival After Liver Transplantation.

    P. Ritschl, L. Wiering, M. Hippler-Benscheidt, F. Aigner, M. Biebl, M. Schmelzle, K. Kotsch, J. Pratschke, R. Öllinger.

    Department of Surgery, Campus Virchow and Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany

    Introduction and BackgroundThe MELD-based allocation system has been implemented in Germany in 2006 in order to decrease waiting list mortality in patients with end stage…
  • 2017 American Transplant Congress

    Neutering Worsens Liver Ischemia/Reperfusion Injury in Both Male and Female Mice.

    D. Murken,1 D. Aufhauser Jr,1 S. Concors,1 Z. Wang,1 G. Ge,1 W. Hancock,2 M. Levine.1

    1Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA; 2Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA

    Introduction: Ischemia/reperfusion injury (IRI) causes significant morbidity in liver transplantation and other surgical scenarios. A better understanding of the molecular mechanisms of IRI is required…
  • 2017 American Transplant Congress

    A Pilot Test of the "Individualized Self-Management Training in Adolescent/Young Adult Recipients of Transplantation (iSTART)" Program.

    E. Fredericks, S. Eder, D. Egleston, W. Newhouse, D. O'Reilly, G. Freed, J. Magee, K. Resnicow.

    University of Michigan, Ann Arbor

    Objective: To pilot test the feasibility and impact of the iSTART program on medication adherence, quality of life, and medication barriers among adolescent/young adult (AYA)…
  • 2017 American Transplant Congress

    PPAR-γ Agonist Attenuates Hepatic Ischemia-Reperfusion Injury in a Mouse Model by Regulating Kupffer Cell Polarization.

    I. Linares, K. Farrokhi, J. Echeverri, M. Kaths, D. Kollman, M. Hamar, P. Urbanellis, S. Ganesh, O. Adeyi, P. Yip, N. Selzner, M. Selzner.

    Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada

    PPAR-γ agonists have shown protective effect on ischemia-reperfusion injury (IRI) in cerebral and renal tissue. The effects of PPAR-γ on hepatic IRI is unclear. We…
  • 2017 American Transplant Congress

    Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets.

    S. Flamm,1 M. Charlton,2 M. Manns,3 M. Prieto,4 I. Fernandez,5 M. Londono,6 R. Kwok,7 C. Smith,8 S. Lee,9 H. Ngo,9 A. Osinusi,9 A. Copans,9 L. Rossaro,9 M. Shoreibah,10 O. Massoud,10 M. Curry,11 M. Bourliere.12

    1Northwestern University, Chicago; 2Intermountain Medical Center, Murray; 3Hannover Medical School, Hannover, Germany; 4Hospital Universitari I Politecnic La Fe, Valencia, Spain; 5Hospital Universitario 12 de Octubre, Madrid, Spain; 6Servicio de Hepatología. Hospital Clinic, Barcelona, Spain; 7Walter Reed National Military Medical Center, DC; 8Medstar Georgetown University Hospital, Georgetown; 9Gilead Sciences, Inc., Foster City; 10University of Alabama Birmingham, Birmingham; 11Beth Israel Deaconess Medical Center, Boston; 12Hospital Saint Joseph, Marsielle, France

    PURPOSE: Post-liver transplant(LT) patients with HCV are considered a difficult-to-treat population. Ledipasvir/sofosbuvir(LDV/SOF) +ribavirin(RBV) for 12 weeks is approved in GT1 LT recipients based on the…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 50
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences